Genetic alterations of the HCCS1 gene in Korean hepatocellular carcinoma

APMIS

Volumn 111, Issue 4, 2003, Pages 465-473

  Xiao, Wenhua ^a   Park, Cheol Keun ^b   Park, Jik Young ^a   Lee, Jong Heun ^a   Kim, Hong Sug ^a   Cho, Yong Goo ^a   Kim, Chang Jae ^a   Ahn, Young Min ^c   Lee, Jong Hoo ^a   Song, Young Hwa ^a   Lee, Sug Hyung ^a   Yoo, Nam Jin ^a   Lee, Jung Young ^a   Park, Won Sang ^a,d  

^a The Catholic University of Korea   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Kyung Hee University   (South Korea)

^d The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Hepatocellular carcinoma; Loss of heterozygosity; Mutation; Polymorphism

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; BREAST CANCER; CANCER GENETICS; CONTROLLED STUDY; DISEASE MARKER; DNA EXTRACTION; EXON; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA EXTRACTION; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOP CODON;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; KOREA; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 0038378743     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2003.1110403.x     Document Type: Article

References (27)

1. Suh CI, Suh KA, Park SH, Chang HJ, Ko JW, Ahn DH. Annual report of the central cancer registry in Korea-1998. J Korean Cancer Assoc 2000;32:827-34.
2. Ogata N, Tokino T, Kamimura T, Asakura H. A comparison of the molecular structure of integrated hepatitis B virus genomes in hepatocellular carcinoma cells and hepatocytes derived from the same patient. Hepatology 1990;11:1017-23.
3. Hino O, Shows TB, Rogler CE. Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17:18 translocation. Proc Natl Acad Sci USA 1986;83:8338-42.
4. Nakamura T, Tokino T, Nagaya T, Matsubara K. Microdeletion associated with the integration process of hepatitis B virus DNA. Nucleic Acids Res 1988;16:4865-73.
5. Bergsland EK. Molecular mechanisms underlying the development of hepatocellular carcinoma. Semin Oncol 2001;28:521-31.
6. Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathway of hepatocarcinogenesis. Gastroenterology 2001;120:1763-73.
7. Fang W, Piao Z, Buyse IM, Simon D, Sheu JC, Perucho M, Huang S. Preferential loss of a polymorphic RI2 allele in human hepatocellular carcinoma. Br J Cancer 2001;84:743-7.
8. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS, Popescu NC. Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 1998;58:2196-9.
9. Fujiwara Y, Ohata H, Kuroki T, Koyama K, Tsuchiya E, Monden M, et al. Isolation of a candidate tumour suppressor gene on chromosome 8p21.3-p22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene 1995;10:891-5.
10. Park WS, Le JH, Park JY, Jeong SW, Shin MS, Kim HS, et al. Genetic analysis of the liver putative tumor suppressor (LPTS) gene in hepatocellular carcinomas. Cancer Lett 2002;178:199-207.
11. Kanai Y, Ushijima S, Hui AM, Ochiai A, Tsuda H, Sakamoto M, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997;71:355-9.
12. Kanai Y, Hui AM, Sun L, Ushijima S, Sakamoto M, Tsuda H, et al. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology 1999;29:703-9.
13. Sun M, Eshleman JR, Ferrell LD, Jacobs G, Sudilovsky EC, Tuthill R, et al. An early lesion in hepatic carcinogenesis: loss of heterozygosity in human cirrhotic livers and dysplastic nodules at the 1p36-p34 region. Hepatology 2001;33:1415-24.
14. Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, et al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroenterol Hepatol 1995;10:179-85.
15. Li SP, Wang HY, Li JQ, Zhang CQ, Feng QS, Huang P, et al. Genome-wide analyses on loss of heterozygosity in hepatocellular carcinoma in Southern China. J Hepatol 2001;34:840-9.
16. Slagle BL, Zhou YZ, Butel JS. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. Cancer Res 1991;51:49-54.
17. Zhao X, Li J, He Y, Lan F, Fu L, Guo J, et al. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma. Cancer Res 2001;61:7383-7.
18. Lee JY, Dong SM, Kim SY, Yoo NJ, Lee SH, Park WS. A simple, precise and economical microdissection technique of analysis of genomic DNA for archival tissue sections. Virchow Arch 1998;433:305-9.
19. Kondoh N, Wakatsuki M, Hada A, Shuda M, Tanaka K, Arai M, et al. Genetic and epigenetic events in human hepatocarcinogenesis. Int J Oncol 2001;18:1271-8.
20. Qin WX, Wan F, Sun FY, Zhang PP, Han LW, Huang Y, et al. Cloning and characterization of a novel gene (C17orf25) from the deletion region on chromosome 17p13.3 in hepatocellular carcinoma. Cell Res 2001;11:209-16.
21. Kishimoto Y, Shiota G, Wada K, Kitano M, Nakamoto K, Kamisaki Y, et al. Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma. J Cancer Res Clin Oncol 1996;122:585-9.
22. Malboeuf CM, Isaacs SJ, Tran NH, Kim B. Thermal effects on reverse transcription improvement of accuracy and processivity in cDNA synthesis. BioTechniques 2001;30:1074-8.
23. Mader RM, Schmidt WM, Sedivy R, Rizovski B, Braun J, Kalipciyan M, et al. Reverse transcriptase template switching during reverse transcriptase-polymerase chain reaction: artificial generation of deletions in ribonucleotide reductase mRNA. J Lab Clin Med 2001;137:422-8.
24. Delviks KA, Pathak VK. Effect of distance between homologous sequence and 3′ homology on the frequency of retroviral reverse transcriptase template switching. J Virol 1999;73:7823-932.
25. Alonso M, Pastori PL. Amplification of FADD mRNA using RT-PCR results in an artifact. BioTechniques 1999;26:828-34.
26. Wang G, Huang CH, Zhao Y, Cai L, Wang Y, Xiu SJ, et al. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23. Cell Res 2000;10:311-23.
27. Pieretti M, Powell DE, Gallion HH, Conway PS, Case EA, Turket MS. Hypermethylation at a chromosome 17 "hot spot" is a common event in ovarian cancer. Hum Pathol 1995;26:398-401.